Literature DB >> 19621301

Surgical treatment of supplementary motor area lesions.

Mustafa Aziz Hatipoğlu1, Sujit Prabhu, Jeffrey Weinberg, Komal Shah, Raymond Sawaya.   

Abstract

Different portions of the SMA appear to be engaged by different types of neurological functions. It is important to identify the functional activation of SMA in terms of planning the surgical strategy. Our unpublished data from M.D. Anderson suggest that resection of the site of SMA activation based on fMRI is an important parameter for predicting the postoperative neurological deficit. Also, protecting the functional SMA during tumor resection may prevent post-operative deficit. Adjunctive non-invasive intraoperative monitoring techniques such as phase reversal of somatosensory evoked potentials, motor evoked potentials monitoring and subcortical stimulation are very important to identify the eloquent cortical brain areas during tumor resection. Delineation of subcortical pathways using diffusion tensor MRI fiber tracking with intraoperative cortical stimulation may also provide improved preservation of eloquent regions during the surgery. Use of preoperative imaging studies including fMRI, diffusion tensor MRI, intraoperative monitoring techniques and awake craniotomies together in suitable cases may minimize the incidence and severity of the SMA syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19621301

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  2 in total

1.  Operative treatment of subcortical metastatic tumours in the central region.

Authors:  J Walter; S A Kuhn; A Waschke; R Kalff; C Ewald
Journal:  J Neurooncol       Date:  2010-09-29       Impact factor: 4.130

2.  An ioMRI-assisted case of cervical intramedullary diffuse glioma resection.

Authors:  Zafer Orkun Toktas; Baran Yilmaz; Murat Şakir Ekşi; Lei Wang; Akin Akakin; Yasin Yener; Murat Konakcı; Emre Ayan; Turker Kılıc; Deniz Konya; Yang D Teng
Journal:  Cancer Manag Res       Date:  2018-10-17       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.